Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and fiscal year 2025 financial results after market close on Thursday, February 12, 2
PHILADELPHIA, Jan. 27, 2026 /PRNewswire/ -- The law firm of Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning DexCom, Inc. (NASDAQ: DXCM) ("Dexco
Intact Investment Management Inc. Has $2.28 Million Stock Position in DexCom, Inc. $DXCM
05:04am, Tuesday, 27'th Jan 2026
Intact Investment Management Inc. boosted its holdings in shares of DexCom, Inc. (NASDAQ: DXCM) by 102.9% in the third quarter, according to its most recent filing with the Securities and Exchange Com
Strs Ohio Sells 14,796 Shares of DexCom, Inc. $DXCM
06:12am, Monday, 26'th Jan 2026
Strs Ohio reduced its stake in shares of DexCom, Inc. (NASDAQ: DXCM) by 6.2% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 224,150 shares of
Campbell & CO Investment Adviser LLC Has $629,000 Holdings in DexCom, Inc. $DXCM
03:51am, Thursday, 22'nd Jan 2026
Campbell and CO Investment Adviser LLC trimmed its position in DexCom, Inc. (NASDAQ: DXCM) by 63.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 9,355 shares
1 Growth Stock Down 19% to Buy Right Now
04:15pm, Wednesday, 21'st Jan 2026
Dexcom's financial performance was strong last year despite some headwinds. The company still has a large market opportunity to tap into.
DexCom, Inc. (NASDAQ:DXCM) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
03:31am, Sunday, 18'th Jan 2026
DexCom, Inc. (NASDAQ: DXCM - Get Free Report) has received a consensus rating of "Moderate Buy" from the twenty-seven analysts that are presently covering the stock, Marketbeat reports. Two analysts h
DexCom Stock Declines Following Strong Preliminary Q4 Results
01:45pm, Friday, 16'th Jan 2026
DXCM posts strong preliminary Q4 and full-year 2025 revenue growth, beating estimates, though shares slip after the announcement.
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
10:35am, Friday, 16'th Jan 2026
DXCM looks poised for growth as CGM demand expands, G7 and One+ adoption accelerates, and strong Q4 results support a hold stance.
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights
12:06pm, Thursday, 15'th Jan 2026
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of DexCom, Inc. (NASDAQ: DXCM) breached their fiduciary duties to shar
Watch CNBC's exclusive interview with Dexcom CEO Jake Leach
05:24pm, Tuesday, 13'th Jan 2026
Jake Leach, Dexcom CEO, joins 'Closing Bell Overtime' to talk its 2026 outlook, the impact of GLP-1s, new devices and more.
DexCom, Inc. (DXCM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
03:35pm, Tuesday, 13'th Jan 2026
DexCom, Inc. (DXCM) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
07:30am, Monday, 12'th Jan 2026
SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook.
Oregon Public Employees Retirement Fund Grows Stock Holdings in DexCom, Inc. $DXCM
06:08am, Monday, 12'th Jan 2026
Oregon Public Employees Retirement Fund grew its stake in shares of DexCom, Inc. (NASDAQ: DXCM) by 32.5% during the undefined quarter, according to the company in its most recent disclosure with the S
Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer
09:00am, Wednesday, 07'th Jan 2026
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq:DXCM), the global leader in glucose biosensing, is ushering in the next era of transformative, customer-driven innovation under the leadership of Presi
